Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. Rupert Christopher Soames OBE (born 18 May 1959) is a British businessman and the former chief executive of Serco from 2014 to 2023. He is a grandson of Winston Churchill, a nephew of one-time Defence Secretary Duncan Sandys and his wife Diana Churchill, of journalist Randolph Churchill, and of actress and dancer Sarah Churchill.

  2. Chair of the Confederation of British Industry. Previous experience. Rupert stepped down in December 2022 after nine years as Group Chief Executive from Serco Group plc, the specialist services business in Health, Defence, Transport and Immigration.

  3. 12 set 2022 · Rupert Soames is to retire as chief executive of Serco after leading the London-listed contractor for more than eight years, saying it was now “time to outsource myself”.

  4. www.cbi.org.uk › about-us › our-peopleRupert Soames OBE | CBI

    15 apr 2024 · Rupert Soames OBE is one of the UK’s most experienced public-company CEOs, having served 11 years as CEO of Aggreko, followed by 9 years as CEO of Serco. He stepped back from full-time executive life in December 2022, and in September 2023 took up the Chair role at Smith & Nephew plc, the FTSE-50 listed medical technology company.

  5. 11 dic 2017 · Mr Soames, now 58, had volunteered for the job of leading Serco, whose public-sector contracts include running prisons in Europe and the Asia-Pacific region; maintaining and supporting RAF ...

  6. 17 feb 2023 · Feb 17 (Reuters) - British medical products maker Smith+Nephew (SN.L) has named Rupert Soames as chairman designate, succeeding Roberto Quarta when he retires this year. Soames, 63, grandson of...

  7. www.confindustria.it › High-Level-Group › Rupert-Soames-ObeSoames OBE Rupert

    31 mag 2024 · Rupert Soames is one of the UK’s most experienced public-company CEO’s, having served 11 years as CEO of Aggreko, followed by 9 years as CEO of Serco. He stepped back from full-time executive life in December 2022, and in September 2023 took up the Chair role at Smith & Nephew plc, the FTSE-50 listed medical technology company.